SNSE
Price
$8.41
Change
-$0.19 (-2.21%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
10.83M
35 days until earnings call
VSTM
Price
$4.16
Change
-$0.14 (-3.26%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
236.28M
Interact to see
Advertisement

SNSE vs VSTM

Header iconSNSE vs VSTM Comparison
Open Charts SNSE vs VSTMBanner chart's image
Sensei Biotherapeutics
Price$8.41
Change-$0.19 (-2.21%)
VolumeN/A
Capitalization10.83M
Verastem
Price$4.16
Change-$0.14 (-3.26%)
Volume$323.05K
Capitalization236.28M
SNSE vs VSTM Comparison Chart in %
Loading...
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SNSE vs. VSTM commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNSE is a Hold and VSTM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (SNSE: $8.60 vs. VSTM: $4.30)
Brand notoriety: SNSE and VSTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SNSE: 90% vs. VSTM: 116%
Market capitalization -- SNSE: $10.83M vs. VSTM: $236.28M
SNSE [@Biotechnology] is valued at $10.83M. VSTM’s [@Biotechnology] market capitalization is $236.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $312.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNSE’s FA Score shows that 1 FA rating(s) are green whileVSTM’s FA Score has 0 green FA rating(s).

  • SNSE’s FA Score: 1 green, 4 red.
  • VSTM’s FA Score: 0 green, 5 red.
According to our system of comparison, SNSE is a better buy in the long-term than VSTM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNSE’s TA Score shows that 6 TA indicator(s) are bullish while VSTM’s TA Score has 4 bullish TA indicator(s).

  • SNSE’s TA Score: 6 bullish, 4 bearish.
  • VSTM’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, SNSE is a better buy in the short-term than VSTM.

Price Growth

SNSE (@Biotechnology) experienced а +14.91% price change this week, while VSTM (@Biotechnology) price change was -17.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.00%. For the same industry, the average monthly price growth was +32.55%, and the average quarterly price growth was +15.13%.

Reported Earning Dates

SNSE is expected to report earnings on Jul 31, 2025.

VSTM is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+2.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VSTM($236M) has a higher market cap than SNSE($10.8M). SNSE YTD gains are higher at: -12.314 vs. VSTM (-16.828). SNSE has higher annual earnings (EBITDA): -27.93M vs. VSTM (-145.04M). SNSE has less debt than VSTM: SNSE (3.21M) vs VSTM (76.8M). VSTM has higher revenues than SNSE: VSTM (10M) vs SNSE (0).
SNSEVSTMSNSE / VSTM
Capitalization10.8M236M5%
EBITDA-27.93M-145.04M19%
Gain YTD-12.314-16.82873%
P/E RatioN/AN/A-
Revenue010M-
Total CashN/A118M-
Total Debt3.21M76.8M4%
FUNDAMENTALS RATINGS
VSTM: Fundamental Ratings
VSTM
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SNSEVSTM
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 21 days ago
85%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DLQIX15.38N/A
N/A
BNY Mellon Large Cap Equity I
DWOAX19.05N/A
N/A
BNY Mellon Research Growth A
VREMX8.39N/A
N/A
Virtus SGA Emerging Markets Equity R6
GEMHX13.06N/A
N/A
Goldman Sachs Emerging Mkts Eq ex. Chn A
OANBX36.82-0.13
-0.35%
Oakmark Equity and Income Institutional

SNSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNSE has been loosely correlated with VSTM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SNSE jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNSE
1D Price
Change %
SNSE100%
+1.48%
VSTM - SNSE
47%
Loosely correlated
-5.70%
GRI - SNSE
40%
Loosely correlated
N/A
ALZN - SNSE
40%
Loosely correlated
-1.02%
INAB - SNSE
38%
Loosely correlated
-2.68%
MOLN - SNSE
36%
Loosely correlated
+3.09%
More

VSTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, VSTM has been loosely correlated with ZLDAF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if VSTM jumps, then ZLDAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VSTM
1D Price
Change %
VSTM100%
-5.70%
ZLDAF - VSTM
47%
Loosely correlated
N/A
SNSE - VSTM
47%
Loosely correlated
+1.48%
NKTX - VSTM
41%
Loosely correlated
+1.71%
SYRE - VSTM
41%
Loosely correlated
+2.01%
IPSC - VSTM
40%
Loosely correlated
-4.74%
More